As we keep talking (and talking and talking) about and waiting (and waiting and waiting) for FDA Guidelines for social media usage, we thought it would be fun to visit this video, from nearly two years ago.
Do you remember this time? Are you still waiting for guidance or are you pushing the boundaries without it?
Tags:FDA·FDA Guidance·FDA guidelines·social media·Social network
In our final interview from the Digital Innovation for Pharma Conference, Darshan Kulkami, principal of the Kulkami Law Firm talks about some of the latest news regarding social media and compliance and what it means for the pharma industry.
Tags:#efp·Compliance·Darshan Kulkami·digital innovation for pharma·FDA·Pixels & Pills·social media
by Jason Brandt (@jasondmg3)
I don’t understand any of this stuff.
Who has the time to really use this stuff anyway?
No real business can afford to have employees wasting their time on this stuff when they should be busy working.
It’s just a geek thing. Nobody with a life really uses this stuff.
It’s just a kid thing. [...]
Tags:business·communication·Digital Tools·Education·engagement·Facebook·FDA·Health care·healthcare·information·innovation·marketing·Patients·Pharmaceutical industry·social media·Social network·Trends
by DJ Edgerton (@wiltonbound)
What do Lady Gaga, Arnold Schwarzenegger and Charlie Sheen have in common? They’re some of the most popular celebrity masks for party revelers this Halloween season. While industry luminaries may not dress up for tricks and treats, many pharma brands are hiding behind their own masks, limiting the ROI in their digital [...]
The Defining Moments series looks back at the biggest events of 2010 to see what we can learn from them here at P&P, to work better in our calling, in 2011 and beyond.
Where were you on Wednesday, October 13, 2010?
I’m willing to bet that, at least at one point [...]
Tags:chilean miners·defining moments·digital strategy·Digital Tools·Education·FDA·Legal Issues·marketing·Pharmaceutical industry·strategy·technology
by Briana Campbell (@MsMatchGirl)
It’s a dog-eat-dog world out there, so for companies to succeed, they need to either dream big or go home. However, in a competitive world, turning a dream into reality requires action.
With social media becoming a formidable communication tool, pharma and health care companies are devising new strategies to communicate with patients, [...]
Tags:communication·digital strategy·Digital Tools·Education·engagement·Facebook·FDA·marketing·media·Pharma·Pharmaceutical industry·social media·Social network·strategy·Trends
by Briana Campbell (@MsMatchGirl)
Wrath. Sloth. Greed. Gluttony. Lust. Envy. Pride.
The seven deadly sins.
In June of this year, PM360 laid out the Seven Deadly Sins of Pharma Marketing (you can take a peek at the digital edition here). And Dave Sonderman laid out his accompanying thoughts on the unintentional sins in a post on the GSW [...]
Tags:#hcmktg·#hcsm·communication·Communities·community·digital strategy·Digital Tools·Education·Facebook·FDA·Health·Health care·healthcare·information·marketing·Pharmaceutical industry·social media·social media platforms·social media strategies·Social network·strategy·Trends·Twitter
by Briana Campbell (@MsMatchGirl)
About a week and a half ago all the talk was about Facebook and its policy changes, disallowing pharmaceutical companies to turn off comments on their walls. Jonathan Richman ran a deathwatch over on Dose of Digital. The Washington Post had a story. We wrote about it, too. Seems like everyone did. [...]
Tags:communication·Communities·community·Facebook·FDA·FDA Guidance·John Mack·Jonathan Richman·NPR·Online community·Pharma·Pharma industry·Pharmaceutical industry·Pharmaguy·social media·Social network·social networks·user needs
by Briana Campbell (@MsMatchGirl)
The talk, for a long while now, has been about Facebook’s change of guidelines, no longer allowing pharmaceutical companies to turn off comments on their Facebook walls. Yesterday, D-Day arrived.
Over on Dose of Digital, Jonathan Richman, was keeping a “deathwatch” vigil over pages that were apt to be removed. On Friday, the [...]
Tags:communication·Communities·community·digital strategy·Digital Tools·engagement·Facebook·FDA·information·innovation·Legal Issues·Pharma·Pharmaceutical industry·social media·Social network·technology
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by Krissy Goelz (@krisgoelz)
When it [...]
Tags:Facebook·FDA·marketing·patient·Patients·Pharma·Pharmaceutical industry·Rx·social media
